Masaomi Nangaku Japan

• Welcome and ISN Presidential Address
  MarcelloTonelli Speaker Canada
• Jean Hamburger Award Presentation
• Welcome Speech by JSN President
  MasaomiNangaku Speaker Japan
• Welcome Speech by APSN President
  XueqingYU Speaker China
• Welcome Speech by SPWG Chair
  Sydney Tang Speaker Hong Kong, China
• Welcome Speech by the President of Japanese Medical Science Federation and Japanese Association of Medical Science
  TakashiKadowaki Speaker Japan
• Dynamics of the Function and Regulation of the Endoplasmic Reticulum
  KazutoshiMori Speaker Japan
• ISN Film Event Winner Presentation

• Advanced Data Science in CKD Management
  YuichiroYano Speaker y.yano@juntendo.ac.jpJapan
• An Integrated Approach to Cardio-Renal-Metabolic Disorders : Addressing Hypertension and Dyslipidemia
  KOUICHITAMURA Speaker Japan

• Opening Remarks and Session Overview
  AdeeraLevin Speaker Canada
• Overcoming the Bottleneck: Endpoint Selection in Phase 2 Kidney Trials
  Kai-UweEckardt Speaker Germany
• Integrating Patient-Reported Outcomes (PROMs)
  Using Patient-reported Outcomes to Improve Kidney Research and Care
  AllisonJaure Speaker Australia

  AnastasiaHughes Speaker Australia

  ChandanaGuha Speaker Australia
• Rethinking Kidney Trials: Innovative Designs for Modern Research Questions
  MegJardine Speaker Australia
• Designing Better Kidney Trials Using Hierarchical Composite Endpoints
  HiddoLambers Heerspink Speaker Netherlands
• Panel Discussion & Q&A
• Closing Remarks
  MasaomiNangaku Speaker Japan

• Mechanistic Effects of Semaglutide on Kidney Disease in Type 2 Diabetes: The REMODEL trial
  KatherineTuttle Speaker United States
• Multiparametric Imaging and Tissue Transcriptomics to Unravel Mechanisms of Kidney Protection
  MatthiasKretzler Speaker United States
• GLP1s in Combination With Other Therapies and Applications in Clinical Practice
  BrendonNeuen Speaker Australia
• The Future of GLP1s and Other Incretin-based Therapies for Kidney Disease
  MasaomiNangaku Speaker Japan

• Is Kidney Dysfunction in Heart Failure More Than Just Low Cardiac Output?
  BrendonNeuen Speaker Australia
• Is Metabolic Dysfunction in Cardiovascular-Kidney-Metabolic Syndrome More Than Just Hyperglycemia and Obesity?
  HiddoLambers Heerspink Speaker Netherlands
• Kidney at the Center of Cardiovascular-Kidney-Metabolic Syndrome
  MasaomiNangaku Speaker Japan
• What’s Next in Cardiovascular-Kidney-Metabolic Therapy?
  RobertoPecoits-Filho Speaker United States
• Q&A

• Welcome & Introductions
  MasaomiNangaku Speaker Japan
• UACR: The hidden marker of heart and kidney risk
  PamelaKushner Speaker United States

  RobertoPecoits-Filho Speaker United States
• Live Q&A
  MasaomiNangaku Moderator Japan
• The Impact of RAAS Dysregulation in Cardiorenal Disease
  Sydney Tang Speaker Hong Kong, China
• Live Q&A
  MasaomiNangaku Moderator Japan
• Closing Remarks
  MasaomiNangaku Moderator Japan

• The Future of Lupus Nephritis: Achieving Renal Protection Through Proteinuria Control
  SHOICHIMARUYAMA Speaker Japan
• A New Era in Lupus Nephritis: Clinical Evidence and Therapeutic Positioning of Triple Therapy
  KeijuHiromura Speaker Japan